Accueil / Formation Recherche / Publications / Publications Histiocytoses

Publications Histiocytoses

Highly sensitive methods are required to detect mutations in histiocytoses.

Langerhans Cell Histiocytoma: A Benign Histiocytic Neoplasm of Diverse Lines of Terminal Differentiation.

Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment.

Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.

BRAF V600E mutation detected in a case of Rosai-Dorfman disease.

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort


Efficacy of infliximab in the treatment of Erdheim-Chester disease.

How I manage pulmonary Langerhans cell histiocytosis. Lorillon G et al. Eur Respir Rev. 2017 Sep 6;26(145).

Current understanding and management of pulmonary Langerhans cell histiocytosis. Vassallo R et al. Thorax. 2017 Oct;72(10):937-945.

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study. Tazi A et al.  Orphanet J Rare Dis. 2017 May 22;12(1):95.

New somatic BRAF splicing mutation in Langerhans cell histiocytosis. Héritier S et al. Mol Cancer. 2017 Jul 6;16(1):115.

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis. Héritier S et al. Br J Haematol. 2017 Aug;178(3):457-467.

Erdheim-Chester disease: the “targeted” revolution. Vaglio A et al. Blood. 2017 Sep 14;130(11):1282-1284.

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Durham BH et al. Blood. 2017 Jul 13;130(2):176-180.

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study). Cohen Aubart F et al. Blood. 2017 Sep 14;130(11):1377-1380.

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis. Papo M et al. Blood. 2017 Aug 24;130(8):1007-1013.

Histiocytoses langerhansienne de l'adulte La Revue de Médecine Interne ; 36(10):658-67 ; Octobre 2015

The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study.


 

ACTUALITÉS

Nouveau cas clinique "Amylose AL"
Testez vos connaissances
Le congrès des Rencontres RARE revient pour sa 6ème édition, les 5 & 6 novembre 2019
Cité des Sciences et de l'Industrie, Paris
Les nouvelles recommandations nationales de prises en charge des aplasies médullaires sont en ligne
Nouveau Protocole National de Diagnostic et de Soins 2019 sur le site de la HAS !
Voir toutes les actualités

AGENDA

18-10-2019 : 12ème Réunion annuelle du centre de référence des microangiopathies thrombotiques CNR MAT, Paris


19-10-2019 : Journée des familles de l'association française de la maladie de Fanconi, Avignon


Du 19-10-2019 au 21-10-2019 : Week-end des Familles de l'association de l'anémie de Blackfan-Diamond, Valençay
Voir tout l'agenda